Federal contract award
HT942524C0021
DHA SEQUENTIAL PHASE II SMALL BUSINESS INNOVATION RESEARCH CONTRACT FOR MEDICAL RESEARCH AND DEVELOPMENT PROJECT TITLED, "MODULAR STABILIZATION OF WHOLE BLOOD COMPONENTS FOR RECONSTITUTION AND TRANSFUSION AT THE POINT OF INJURY"
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | DEFENSE HEALTH AGENCY |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $1.3M |
| Current contract value | $1.3M |
| Potential contract value / ceiling | $1.3M |
| Start date | Mar 25, 2024 |
| Current end date | Nov 24, 2026 |
| Potential end date | Nov 24, 2026 |
| Latest award activity | Apr 29, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 29, 2026 | P00003 | $0 | MODULAR STABILIZATION OF WHOLE BLOOD COMPONENTS FOR RECONSTITUTION AND TRANSFUSION AT THE POINT OF INJURY |
| Apr 17, 2026 | P00002 | $0 | MODULAR STABILIZATION OF WHOLE BLOOD COMPONENTS FOR RECONSTITUTION AND TRANSFUSION AT THE POINT OF INJURY |
| Sep 16, 2025 | P00001 | $0 | CHANGE IN STATEMENT OF WORK- SEE HIGHLIGHTS ABOVE |
| Mar 21, 2024 | 0 | $1.3M | DHA SEQUENTIAL PHASE II SMALL BUSINESS INNOVATION RESEARCH CONTRACT FOR MEDICAL RESEARCH AND DEVELOPMENT PROJECT TITLED, "MODULAR STABILIZATION OF WHOLE BLOOD COMPONENTS FOR RECONSTITUTION AND TRANSFUSION AT THE POINT OF INJURY" |
Estimated positioning window
Nov 1, 2026 – Jan 30, 2027
80/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 80/100. Available recorded signals: 75 points.
- Contract end 2026-11-24 (23 days from calculation)
- +35 points
- 48 historical awards in this buyer and category group
- +15 points
- 4 recorded award transactions
- +10 points
- Latest award action: 2026-04-29
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.